Mark DeBrunner, M.D.

  • Assistant Professor of Pediatrics 
  • Director, Pediatric Cardiology Fellowship Program

Major Lectureships and Seminars

  • “Atrioventricular Septal Defect in the Setting of Isomerism of the Atrial Appendages,” 9th Annual Master Class in Congenital Cardiac Morphology, Pittsburgh, Pa., September 2016
  • “The Pulmonary Valve,” 9th Annual Master Class in Congenital Cardiac Morphology, Pittsburgh, Pa., September 2016

Professional Affiliations/Society Memberships

  • AAP
  • Society of Pediatric Cardiology Training Program Directors

Education & Training

  • MD: Wright State University School of Medicine Dayton, OH
  • Residency: Nationwide Children's Hospital Columbus, OH
  • Fellowship: J W Riley Hospital for Children Indianapolis, IN

Research Interests

Use of the Myocardial Performance Index (MPI) Derived by Echocardiography to Identify Rejection in Patients after Heart Transplant. Standard, noninvasive imaging has not proven to be very effective in identifying patients with rejection following heart transplantation. The MPI, derived through Doppler and tissue Doppler measurements, has been used to measure subtle forms of myocardial dysfunction. This retrospective study utilized a large transplant database and confirmed that the MPI calculated with spectral Doppler predicts cardiac transplant rejection. Ongoing studies will utilize tissue Doppler indices to measure MPI in a prospective fashion.

Additionally, Mark DeBrunner participated in the “Brain Dysplasia Associated with Ciliary Dysfunction in Infants with Congenital Heart Disease” study

Division